{"name":"Azienda Socio Sanitaria Territoriale degli Spedali Civili di Brescia","slug":"azienda-socio-sanitaria-territoriale-degli-spedali-civili-di-brescia","ticker":"","exchange":"","domain":"","description":"","hq":"","founded":0,"employees":"","ceo":"","sector":"","stockPrice":0,"stockChange":0,"stockChangePercent":0,"marketCap":"","metrics":{"revenue":0,"revenueGrowth":0,"grossMargin":0,"rdSpend":0,"netIncome":0,"cash":0,"dividendYield":0,"peRatio":0,"fiscalYear":"FY2026"},"revenueBreakdown":[],"timeline":[{"date":"2026-07-28","label":"Q2 2026 Earnings","type":"earnings","sentiment":"neutral"},{"date":"2026-10-28","label":"Q3 2026 Earnings","type":"earnings","sentiment":"neutral"},{"date":"2027-01-28","label":"Q4 2027 Earnings","type":"earnings","sentiment":"neutral"},{"date":"2027-04-28","label":"Q1 2027 Earnings","type":"earnings","sentiment":"neutral"},{"date":"2027-07-28","label":"Q2 2027 Earnings","type":"earnings","sentiment":"neutral"},{"date":"2027-10-28","label":"Q3 2027 Earnings","type":"earnings","sentiment":"neutral"}],"diseaseAreas":[{"name":"Other","slug":"other","revenue":0,"percentOfTotal":0,"drugCount":4,"colorKey":"immunology","drugs":[{"name":"Betaine taurine PVP gel","genericName":"Betaine taurine PVP gel","slug":"betaine-taurine-pvp-gel","indication":"Wound healing and tissue repair (specific indication not publicly detailed)","status":"phase_3"},{"name":"LATANOPROST 0.005% EYEDROPS","genericName":"LATANOPROST 0.005% EYEDROPS","slug":"latanoprost-0-005-eyedrops","indication":"Other","status":"marketed"},{"name":"TAFLUPROST 0.0015% EYEDROPS","genericName":"TAFLUPROST 0.0015% EYEDROPS","slug":"tafluprost-0-0015-eyedrops","indication":"Other","status":"marketed"},{"name":"Xylitol, Lactoperoxidase, Lysozyme, Lactoferrin","genericName":"Xylitol, Lactoperoxidase, Lysozyme, Lactoferrin","slug":"xylitol-lactoperoxidase-lysozyme-lactoferrin","indication":"Prevention of dental caries","status":"phase_3"}]},{"name":"Cardiovascular","slug":"cardiovascular","revenue":0,"percentOfTotal":0,"drugCount":2,"colorKey":"oncology","drugs":[{"name":"RASS inhibitors and/or RAS blockers","genericName":"RASS inhibitors and/or RAS blockers","slug":"rass-inhibitors-and-or-ras-blockers","indication":"Hypertension","status":"phase_3"},{"name":"Latanoprost, Dorzolamide","genericName":"Latanoprost, Dorzolamide","slug":"latanoprost-dorzolamide","indication":"Open-angle glaucoma","status":"marketed"}]},{"name":"Oncology","slug":"oncology","revenue":0,"percentOfTotal":0,"drugCount":1,"colorKey":"cardiovascular","drugs":[{"name":"Cisplatin plus Etoposide","genericName":"Cisplatin plus Etoposide","slug":"cisplatin-plus-etoposide","indication":"Small cell lung cancer","status":"phase_3"}]}],"pipeline":[{"name":"RASS inhibitors and/or RAS blockers","genericName":"RASS inhibitors and/or RAS blockers","slug":"rass-inhibitors-and-or-ras-blockers","phase":"phase_3","mechanism":"RASS inhibitors and RAS blockers suppress the renin-angiotensin-aldosterone system to reduce vasoconstriction, lower blood pressure, and decrease sodium retention.","indications":["Hypertension","Heart failure","Chronic kidney disease","Post-myocardial infarction"],"catalyst":""},{"name":"Betaine taurine PVP gel","genericName":"Betaine taurine PVP gel","slug":"betaine-taurine-pvp-gel","phase":"phase_3","mechanism":"Betaine and taurine in a PVP gel formulation work synergistically to promote wound healing and tissue repair through osmotic and cytoprotective effects.","indications":["Wound healing and tissue repair (specific indication not publicly detailed)"],"catalyst":""},{"name":"Cisplatin plus Etoposide","genericName":"Cisplatin plus Etoposide","slug":"cisplatin-plus-etoposide","phase":"phase_3","mechanism":"Cisplatin and etoposide work together as chemotherapy agents—cisplatin cross-links DNA to prevent replication, while etoposide inhibits topoisomerase II to block DNA unwinding and repair.","indications":["Small cell lung cancer","Testicular cancer","Ovarian cancer","Lymphomas"],"catalyst":""},{"name":"LATANOPROST 0.005% EYEDROPS","genericName":"LATANOPROST 0.005% EYEDROPS","slug":"latanoprost-0-005-eyedrops","phase":"marketed","mechanism":"Small molecule","indications":[],"catalyst":""},{"name":"Latanoprost, Dorzolamide","genericName":"Latanoprost, Dorzolamide","slug":"latanoprost-dorzolamide","phase":"marketed","mechanism":"This combination reduces intraocular pressure by increasing uveoscleral outflow of aqueous humor (latanoprost) and decreasing aqueous humor production (dorzolamide).","indications":["Open-angle glaucoma","Ocular hypertension"],"catalyst":""},{"name":"TAFLUPROST 0.0015% EYEDROPS","genericName":"TAFLUPROST 0.0015% EYEDROPS","slug":"tafluprost-0-0015-eyedrops","phase":"marketed","mechanism":"Small molecule","indications":[],"catalyst":""},{"name":"Xylitol, Lactoperoxidase, Lysozyme, Lactoferrin","genericName":"Xylitol, Lactoperoxidase, Lysozyme, Lactoferrin","slug":"xylitol-lactoperoxidase-lysozyme-lactoferrin","phase":"phase_3","mechanism":"Xylitol inhibits bacterial adhesion and biofilm formation, while Lactoperoxidase, Lysozyme, and Lactoferrin have antimicrobial properties.","indications":["Prevention of dental caries"],"catalyst":""}],"recentEvents":[],"realNews":[],"patents":[],"drugCount":7,"phaseCounts":{"phase_3":4,"marketed":3},"enrichmentLevel":0,"visitCount":2,"keyCompetitors":[],"therapeuticFocus":[],"financials":null,"yahoo":null}